|
Market Closed -
NYSE
16:00:02 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 130.22 USD | -0.31% |
|
+1.20% | +34.59% |
| 09-04 | KeyBanc Adjusts Price Target on Revvity to $165 From $125, Maintains Overweight Rating | MT |
| 09-04 | Analyst recommendations: Microsoft, DocuSign, Intuit, Lululemon Athletica, Zscaler… |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Advanced Medical Equipment & Technology
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 14.53B | |||||
| 227B | |||||
| 146B | |||||
| 130B | |||||
| 69.27B | |||||
| 51.82B |
- Stock Market
- Stocks
- RVTY Stock
- Charts Revvity, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
